NEW DELHI (Reuters) – The India launch of a new COVID-19 vaccine jointly developed by the Serum Institute of India and US-based biotech firm Novavax is likely to be delayed until September, …
Read More »Serum Institute delays expected launch of Novavax vaccine in India
